These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 27770540)
1. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540 [TBL] [Abstract][Full Text] [Related]
2. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia. Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Li Y; Gao L; Luo X; Wang L; Gao X; Wang W; Sun J; Dou L; Li J; Xu C; Wang L; Zhou M; Jiang M; Zhou J; Caligiuri MA; Nervi C; Bloomfield CD; Marcucci G; Yu L Blood; 2013 Jan; 121(3):499-509. PubMed ID: 23223432 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia. Yang E; Guan W; Gong D; Gao X; Han C; Zhang J; Wang H; Wang M; Li Y; Yu L Clin Sci (Lond); 2020 Dec; 134(23):3079-3091. PubMed ID: 33201243 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Yang E; Guan W; Gong D; Li J; Han C; Zhang J; Wang H; Kang S; Gao X; Li Y; Yu L Exp Mol Med; 2021 Dec; 53(12):1902-1910. PubMed ID: 34921223 [TBL] [Abstract][Full Text] [Related]
7. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia. Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Tonks A; Pearn L; Musson M; Gilkes A; Mills KI; Burnett AK; Darley RL Leukemia; 2007 Dec; 21(12):2495-505. PubMed ID: 17898786 [TBL] [Abstract][Full Text] [Related]
9. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288 [TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA. Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160 [TBL] [Abstract][Full Text] [Related]
12. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Redondo Monte E; Wilding A; Leubolt G; Kerbs P; Bagnoli JW; Hartmann L; Hiddemann W; Chen-Wichmann L; Krebs S; Blum H; Cusan M; Vick B; Jeremias I; Enard W; Theurich S; Wichmann C; Greif PA Oncogene; 2020 Apr; 39(15):3195-3205. PubMed ID: 32115572 [TBL] [Abstract][Full Text] [Related]
13. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704 [TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987 [TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals. Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335 [TBL] [Abstract][Full Text] [Related]
16. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis. Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196 [TBL] [Abstract][Full Text] [Related]
18. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1. Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541 [TBL] [Abstract][Full Text] [Related]
19. Decoding of exon splicing patterns in the human RUNX1-RUNX1T1 fusion gene. Grinev VV; Migas AA; Kirsanava AD; Mishkova OA; Siomava N; Ramanouskaya TV; Vaitsiankova AV; Ilyushonak IM; Nazarov PV; Vallar L; Aleinikova OV Int J Biochem Cell Biol; 2015 Nov; 68():48-58. PubMed ID: 26320575 [TBL] [Abstract][Full Text] [Related]
20. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Ptasinska A; Assi SA; Mannari D; James SR; Williamson D; Dunne J; Hoogenkamp M; Wu M; Care M; McNeill H; Cauchy P; Cullen M; Tooze RM; Tenen DG; Young BD; Cockerill PN; Westhead DR; Heidenreich O; Bonifer C Leukemia; 2012 Aug; 26(8):1829-41. PubMed ID: 22343733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]